Incidentalomas adrenales. Unas sorpresas inesperadas
PDF (Español (España))
HTML (Español (España))

Keywords

Incidentalomas adrenales
enfermedades adrenales
estudios imaginológicos adrenales
andrógenos adrenales

How to Cite

Orrego M., A. (2017). Incidentalomas adrenales. Unas sorpresas inesperadas. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 4(1), 16–21. https://doi.org/10.53853/encr.4.1.103

Abstract

Es de esperar que la incidencia de los incidentalomas aumente más debido a una mayor resolución de la TAC y a su uso indiscriminado ante la presencia de síntomas inespecíficos. Los autores recomiendan la utilización de métodos imaginológicos con posibilidades de definir el potencial de malignidad en los incidentalomas adrenales. La tomografía axial computarizada sin medio de contraste para el estudio del coeficiente de atenuación del incidentaloma adrenal es el método más aconsejado para diferenciar entre adenomas benignos o malignos, la hiperplasia, las lesiones quísticas, y los tumores malignos.
En todos los pacientes con incidentaloma adrenal está indicada la búsqueda del probable exceso hormonal. Los pacientes portadores de incidentalomas adrenales pobres en grasa se deben investigar para feocromocitomas, no importa si presentan o no hipertensión arterial.
El hiperaldosteronismo primario debe sospecharse en pacientes hipertensos e hipocaliémicos. Se deben investigar los andrógenos adrenales en pacientes con signos de hiperandrogenismo. Se debe llevar a cabo la identificación de los incidentalomas adrenales, ya que se ha demostrado que estos tumores pueden tener relación con varios riesgos cardiovasculares.
La cirugía está indicada para la mayoría de los incidentalomas adrenales hipersecretores y para aquellos sospechosos de malignidad.

 

https://doi.org/10.53853/encr.4.1.103
PDF (Español (España))
HTML (Español (España))

References

1. Korobkin M, White EA, Kressel HY, et al. Computed tomography in the diagnoses of adrenal disease. AJRAm J Roentgenol. 1979; 132 (2): 231-238.
2. Young WF Jr. Management approaches to adrenal incidentalomas. A review from Rochester Minimesota. Endocrinal Metab Clin North Am. 2000; 29(1): 159-85
3. Kloos RT, Gross MD, Francis IR. Incidentally discovered adrenal masses. Endocr. 19955; 16(4): 460-84.
4. Young WF.Jr. Clinical practice. The incintally discovered adrenal mass. N Engl J Med. 2007; 356 (6): 601-610.
5. Kawano M, Kodama T, Ito Y, et al. Adrenal incidentaloma-report of 14 operated cases and analysis of 4-year autopsy series of Japan. Nihon Geka Gakkai Zasshi. 1989; 90(12): 2031-2036.
6. Kannan S, Remer EM, Hamrahian AH. Evaluacion of patients with adrenal incidentalomas. Curr Opin Endorinol. Diabetes Obes. 2013; 20(3): 161-169.
7. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a computarized tomograhy series. J Endocrinol F Invest, 2006; 29 (4): 298.
8. Davenport C, Liew A, Doherty B, et al. The prevalence of adrenal indicentaloma in routine clinical practice. Endocrine. 2011; 40(1): 80-83.
9. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of The Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000,85(2): 637-644.
10. Kim J, Bae KH, Choi YK, et al. Clinical Characteristics for 348 patients with adrenal incidentaloma. Endocrinol Metab (Seoul). 2012; 28(1): 20-25.
11. Kasperlik- Zaluska AA, Otto M, Cichocki A, et al. Incidentally discovered adrenal tumors: a lesson from observation of 1444 patients. Horm Metab Res. 2008: 40 (5): 338-341.
12. Bulow B, Janson S, Juhlin C, et al. Adrenal incidentaloma-follow-up results from a swedish prospective study . Eur J Endocrinol. 2006; 154(3): 419- 423.
13. Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011; 164(6): 851-870.
14. Kim HY, Kimi SG, Lee KW, et al. Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med. 2005; 20(4): 303-309.
15. Barzon L, Fallo F , Sonino N, et al. Development of overt Cushing´s síndrome in patients with adrenal incidentaloma. Eur J Endocrinol. 2002: 146(1): 61- 66
16. Angeli A, Osella G, Ali A, et al. Adrenal incidentaloma: An overview of data from The National Italian Study Group. Horm Res. 1997; 47 (4): 279-283.
17. Alguraan Z, Agcaoglu O, El- Hayek K, et al. Retroperitioneal masses mimick ing adrenal tumors. Endocr Practice 2012; 18(3): 335-341.
18. Jaresch S, Kornely E, Kley HK, et al. Adrenal incidentaloma and patients with homozygous o heterozygous congenital adrenal hiperplasia. J clin Endocrinol Metab. 1992; 74(3): 685-689.
19. Barzon L, Sinino N,Fallo F, et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003; 149(4): 273-285.
20. Musella M, Conzo G,Milone M, et al. Preoperative Work up in the assessment f adrenal incidentaloma: outcome from 282 consecutive laparascopic adrenalectomies. B MC Surg. 2013; 3:57-65.
21. Sturgeon C,Shen WT, Clark OH, et al. Risk assessment in 457 adrenal cortical carcinomas: how much tumor size predict the likelihood of malignancy? J Am Coll Surg. 2006: 202 (3): 423-430.
22. McDermontt S, O´Connor OJ, Cronin OH, et al. Radiological evaluation of adrenal incidentalomas: currents methods and future prospects. Best Pract Res Clin Endocrinol Metab. 2012, 26(1): 21-33.
23. Hamrahian AH, Loachescu AG, Remer EM, et al. Clinical utility of noncontrast computed tomography attenuation value ( Hounsfield units) to: differentiate adrenal adenoma/hiperplasias from nonadenomas: Cleveland Clinic experience. J CLin Endocrinol Metab 2005; 90(2): 871-877.
24. Korobkin M, Brodeur FJ, Yutzy GG, et al. Diferentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996; 166(3): 531-536.
25. Lee MJ, Hahn PF, Papanicolaou N,et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size and abserver analysis. Radiology. 199; 179(2): 415-418.
26. Mayo- Smith WW, Boland Gw, Noto RB, et al. State-of-the art adrenal imaging. Radiographics. 2001;21(4): 995-1012.
27. Caoili EM, Korobkin M, Francis IR, et al. Adrena masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 2002;222(3): 629-633.
28. Kamiyama T, Fukukura Y, Yoneyama T, et al. Distinguishing adenomas from nonadenomas: Combined use of diagnstic parameters of unenhanced and short 5-minute dynamic enhaced CT protocol. Radiology. 2009; 250 (2): 471-481.
29. Korobkin M, Brodeur FJ, Francis IR, et al. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology. 1996;200(3): 737-742.
30. Timmers HJ, Chen CC, Carrasquillo JA, et al. Staging and funcional characterization of pheocromocytoma and paraganglioma by 18F-fluorodeoxy- glucose (18F-FDG) positron emisión tomograhy . J Natl Cancer Inst. 2012; 104(9): 700-.708.
31. Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fluoro-L- DOPA, 18F-fluorodeoxyglucose, and 18F-fluorodopamine PET and 123- MIBG scintigraphy in the localization of preochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009; 94 (12) 4757-4767.
32. Ioachimescu GA, Remer ME, Hamrahian HA. Adrenal Incidentalomas. A disease of modern techhonology. Offering oportunities for improved patients care. Adrenal Cortical Neoplasia. 2015;44(2): 335-354.
33. Herrera MF, Grant CS, Van Heerden JA, et al. Incidentally discovered adrenal tumor: an instutional perspective. Surgery. 1991; 110(6): 1014-1021.
34. Eldeiry LS, Garber JR. Adrenal Incidentalomas, 2003 to 2005: experience after publication of the National Institute of Health Consensus Statement. Endocr Pract. 2008;14(3): 279-284.
35. Morelli V, Reimondo G, Giordano R, et al. Long- term follow-up in adre- nal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab. 2014;99(3): 827-834.

Authors must state that they reviewed, validated and approved the manuscript's publication.  Moreover, they must sign a model release that should be sent.  A copy may be reviewed here

Dimensions


PlumX


Downloads

Download data is not yet available.